Product
Pegzilarginase
2 clinical trials
2 indications
Indication
Arginase I DeficiencyIndication
ArgininemiaClinical trial
A Phase 3 Open-Label Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 DeficiencyStatus: Terminated, Estimated PCD: 2023-04-27
Clinical trial
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 DeficiencyStatus: Completed, Estimated PCD: 2023-01-27